Abstract
The incidence of MRSA or MRSE type infections involving hip prostheses is increasing. Treatment often involves removal of the prosthesis followed by a defined period of antibiotic treatment, prior to insertion of a second prosthesis. Vancomycin is often used in this setting. We report a fatal case of toxic epidermal necrolysis (TEN) in a patient receiving vancomycin following a first stage revision hip replacement. With the increasing use of vancomycin in revision arthroplasty cases, knowledge of this rare but commonly fatal side effect is important so that if it occurs, rapid and appropriate treatment may be commenced. (Hip International 2004; 14: 58-61).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
